Email me when Ian Jacobs files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Orielle Acquisition Corp. | Common Stock, par value $0.0001 per share | 5% | 250K | Ian Jacobs | Sep 30, 2025 | ||||
| Lomond Therapeutics Holdings, Inc. | Common Stock, par value $0.0001 per share | 0.59% | 175K | Ian Jacobs | Dec 31, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|